Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Singer

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Oncotarget|March 26, 2016
Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC)Juliane Winkler, Stephanie Roessler, Carsten Sticht, et al.
Frontiers in Oncology|April 22, 2025
Case Report: FGFR2 inhibitor resistance via <i>PIK3CA</i> and <i>CDKN2A/B</i> in an intrahepatic cholangiocarcinoma patient with <i>FGFR2-SH3GLB1</i> fusionNadja Ballin, Alexander Ott, Olga Seibel-Kelemen, et al.
Cancers|December 30, 2025
Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and OutcomesRaphaela D Lewetag, Nils F Trautwein, Monika Zdanyte, et al.
Cells|October 23, 2021
Hormonally Induced Hepatocellular Carcinoma in Diabetic Wild Type and Carbohydrate Responsive Element Binding Protein Knockout MiceVincent Nuernberger, Sharif Mortoga, Christoph Metzendorf, et al.
Oncogenesis|December 28, 2022
LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescenceAndreas Konopa, Melanie A Meier, Miriam J Franz, et al.
Oncogene|December 18, 2019
Inhibition of TRPM7 blocks MRTF/SRF-dependent transcriptional and tumorigenic activitySandra Voringer, Laura Schreyer, Wiebke Nadolni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2025
One-day dual-tracer examination in neuroendocrine neoplasms: a real advantage of low activity LAFOV PET imagingEduardo Calderón, Lena S Kiefer, Fabian P Schmidt, et al.
Clinical Nuclear Medicine|January 25, 2024
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot StudyNils Florian Trautwein, Clemens Hinterleitner, Lena Sophie Kiefer, et al.
Journal for Immunotherapy of Cancer|October 9, 2025
Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking caseAna Maia, Juliane Schuhmacher, Silvio Nadalin, et al.
British Journal of Cancer|September 6, 2022
Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesisAlphonse Charbel, Luca Tavernar, Thomas Albrecht, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Oncotarget|March 26, 2016
Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC)Juliane Winkler, Stephanie Roessler, Carsten Sticht, et al.
Frontiers in Oncology|April 22, 2025
Case Report: FGFR2 inhibitor resistance via <i>PIK3CA</i> and <i>CDKN2A/B</i> in an intrahepatic cholangiocarcinoma patient with <i>FGFR2-SH3GLB1</i> fusionNadja Ballin, Alexander Ott, Olga Seibel-Kelemen, et al.
Cancers|December 30, 2025
Cardiac Metastases in Neuroendocrine Neoplasms: A Single-Center Experience of Clinical Characteristics and OutcomesRaphaela D Lewetag, Nils F Trautwein, Monika Zdanyte, et al.
Cells|October 23, 2021
Hormonally Induced Hepatocellular Carcinoma in Diabetic Wild Type and Carbohydrate Responsive Element Binding Protein Knockout MiceVincent Nuernberger, Sharif Mortoga, Christoph Metzendorf, et al.
Oncogenesis|December 28, 2022
LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescenceAndreas Konopa, Melanie A Meier, Miriam J Franz, et al.
Oncogene|December 18, 2019
Inhibition of TRPM7 blocks MRTF/SRF-dependent transcriptional and tumorigenic activitySandra Voringer, Laura Schreyer, Wiebke Nadolni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 30, 2025
One-day dual-tracer examination in neuroendocrine neoplasms: a real advantage of low activity LAFOV PET imagingEduardo Calderón, Lena S Kiefer, Fabian P Schmidt, et al.
Clinical Nuclear Medicine|January 25, 2024
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot StudyNils Florian Trautwein, Clemens Hinterleitner, Lena Sophie Kiefer, et al.
Journal for Immunotherapy of Cancer|October 9, 2025
Exceptional tumor-free survival of a patient with metastatic intrahepatic cholangiocarcinoma after surgery and personalized peptide vaccination: revisiting a striking caseAna Maia, Juliane Schuhmacher, Silvio Nadalin, et al.
British Journal of Cancer|September 6, 2022
Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesisAlphonse Charbel, Luca Tavernar, Thomas Albrecht, et al.
Pageof 10